Latest data from the Hong Kong Stock Exchange shows that on December 10, China International Capital Corporation Limited (CICC) acquired an additional 105,200 shares of NOVOSENSE (02676) at HK$115.737 per share, totaling approximately HK$12.18 million. Following this transaction, CICC's total holdings in the company reached about 2.94 million shares, representing a 15.43% stake.